A one-year fellowship has been created to allow the successful candidate to gain clinical and research experience in Uro–Oncology. The particular emphasis of this fellowship will be towards the technological advances in Radiation Oncology. The fellowship will allow you to gain in depth experience in advanced radiotherapy techniques such as intensity modulated radiotherapy, advanced image-guided radiotherapy using the MR-Linac and brachytherapy. There will also be the opportunity to gain experience in phase I–III systemic therapy trials and pursue original research projects.
This is your opportunity to launch a career in world-leading cancer research. You will play your part in our overall strategy to drive the adoption of more personalised treatment approaches. We are looking for candidates with ambition, commitment and a strong desire to develop a career in cancer research.
This position is suitable for individuals who wish to gain specialist training in advanced radiotherapy research. The post holder is required to have obtained a FRCR qualification or equivalent prior to commencing this post.
This post is for 40 hours per week to provide support for Uro-Oncology clinics plus bladder and prostate cancer research taking place in the Radiotherapy Related Research Group within the department of Clinical Oncology.
The Uro-Oncology team involves 10 Consultants, 2 Sub-specialty Trainee and 2 Clinical Fellows. We are supported by a team of 4 Clinical Nurse Specialists. We are friendly, hard-working team focused on delivering high quality patient-centred care. We encourage all members of the team to engage in SMDT, clinics and inpatient care.
The Urology (prostate, urothelial & penile only) Research team consists of 4 Clinical Research Nurses, 5 Clinical Trial Coordinators and 1 Research Nurse Team Leader. We have a team of 8 research radiographers led by a team leader who implement radiotherapy (RT) clinical trials including access to advanced technologies such as MR-Linac and protons.
On average, the team can be managing 20 recruiting studies and 20 studies in follow-up with Principal Investigators across clinical oncology and surgery.
We have access to a National Institute for Health Research Clinical Research Facility on-site. This facility gives us access to a dedicated unit to treat patients on trials and a research laboratory to process clinical
Radiotherapy Related Research Group has world-leading collaborative researchers in RT immunology, radiobiology, biomarkers, pre-clinical drug RT combination studies, RT physics, computational oncology and Proton Beam Therapy. Its ambition is to drive Phase I-III clinical trials with state-of-the art radiotherapy, alongside imaging and biological prognostic and predictive biomarker development including genomics, transcriptomics and proteomics.
For further details / informal visits contact: Name: Professor Ananya Choudhury Job title: Chair and Honorary Consultant in Clinical Oncology Email address: ananya.choudhury@nhs.net Telephone number: 0845 226 3000
